Literature DB >> 33526170

Iron derived from autophagy-mediated ferritin degradation induces cardiomyocyte death and heart failure in mice.

Jumpei Ito1,2, Shigemiki Omiya1, Mara-Camelia Rusu1, Hiromichi Ueda3, Tomokazu Murakawa1, Yohei Tanada1, Hajime Abe1, Kazuki Nakahara1, Michio Asahi2, Manabu Taneike1,3, Kazuhiko Nishida1, Ajay M Shah1, Kinya Otsu1.   

Abstract

Heart failure is a major public health problem, and abnormal iron metabolism is common in patients with heart failure. Although iron is necessary for metabolic homeostasis, it induces a programmed necrosis. Iron release from ferritin storage is through nuclear receptor coactivator 4 (NCOA4)-mediated autophagic degradation, known as ferritinophagy. However, the role of ferritinophagy in the stressed heart remains unclear. Deletion of Ncoa4 in mouse hearts reduced left ventricular chamber size and improved cardiac function along with the attenuation of the upregulation of ferritinophagy-mediated ferritin degradation 4 weeks after pressure overload. Free ferrous iron overload and increased lipid peroxidation were suppressed in NCOA4-deficient hearts. A potent inhibitor of lipid peroxidation, ferrostatin-1, significantly mitigated the development of pressure overload-induced dilated cardiomyopathy in wild-type mice. Thus, the activation of ferritinophagy results in the development of heart failure, whereas inhibition of this process protects the heart against hemodynamic stress.
© 2021, Ito et al.

Entities:  

Keywords:  autophagy; biochemistry; chemical biology; ferritin; heart failure; iron; medicine; mouse; necrosis

Mesh:

Substances:

Year:  2021        PMID: 33526170      PMCID: PMC7853718          DOI: 10.7554/eLife.62174

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  39 in total

Review 1.  Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury.

Authors:  Christopher A Papaharalambus; Kathy K Griendling
Journal:  Trends Cardiovasc Med       Date:  2007-02       Impact factor: 6.677

2.  Iron Supply via NCOA4-Mediated Ferritin Degradation Maintains Mitochondrial Functions.

Authors:  Motoki Fujimaki; Norihiko Furuya; Shinji Saiki; Taku Amo; Yoko Imamichi; Nobutaka Hattori
Journal:  Mol Cell Biol       Date:  2019-06-27       Impact factor: 4.272

Review 3.  Cell death in the pathogenesis of heart disease: mechanisms and significance.

Authors:  Russell S Whelan; Vladimir Kaplinskiy; Richard N Kitsis
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

Review 4.  The transport of glutamine into mammalian cells.

Authors:  John D McGivan; Claire I Bungard
Journal:  Front Biosci       Date:  2007-01-01

5.  p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload.

Authors:  Kazuhiko Nishida; Osamu Yamaguchi; Shinichi Hirotani; Shungo Hikoso; Yoshiharu Higuchi; Tetsuya Watanabe; Toshihiro Takeda; Soh Osuka; Takashi Morita; Gen Kondoh; Yoshihiro Uno; Kazunori Kashiwase; Masayuki Taniike; Atsuko Nakai; Yasushi Matsumura; Jun-ichi Miyazaki; Tatsuhiko Sudo; Kenichi Hongo; Yoichiro Kusakari; Satoshi Kurihara; Kenneth R Chien; Junji Takeda; Masatsugu Hori; Kinya Otsu
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

6.  Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure.

Authors:  Hisao Hirota; Masahiro Izumi; Tomoyuki Hamaguchi; Shoko Sugiyama; Eiki Murakami; Keita Kunisada; Yasushi Fujio; Yuichi Oshima; Yoshikazu Nakaoka; Keiko Yamauchi-Takihara
Journal:  Heart Vessels       Date:  2004-09       Impact factor: 2.037

7.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

8.  Insight into the mechanism of ferroptosis inhibition by ferrostatin-1.

Authors:  Giovanni Miotto; Monica Rossetto; Maria Luisa Di Paolo; Laura Orian; Rina Venerando; Antonella Roveri; Ana-Marija Vučković; Valentina Bosello Travain; Mattia Zaccarin; Lucio Zennaro; Matilde Maiorino; Stefano Toppo; Fulvio Ursini; Giorgio Cozza
Journal:  Redox Biol       Date:  2019-09-20       Impact factor: 11.799

9.  Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models.

Authors:  Rachid Skouta; Scott J Dixon; Jianlin Wang; Denise E Dunn; Marina Orman; Kenichi Shimada; Paul A Rosenberg; Donald C Lo; Joel M Weinberg; Andreas Linkermann; Brent R Stockwell
Journal:  J Am Chem Soc       Date:  2014-03-14       Impact factor: 15.419

Review 10.  Iron and Heart Failure: Diagnosis, Therapies, and Future Directions.

Authors:  Kambiz Ghafourian; Jason S Shapiro; Lauren Goodman; Hossein Ardehali
Journal:  JACC Basic Transl Sci       Date:  2020-03-23
View more
  14 in total

Review 1.  Ascorbate as a Bioactive Compound in Cancer Therapy: The Old Classic Strikes Back.

Authors:  Jaime González-Montero; Silvia Chichiarelli; Margherita Eufemi; Fabio Altieri; Luciano Saso; Ramón Rodrigo
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

Review 2.  The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease.

Authors:  Xuexian Fang; Hossein Ardehali; Junxia Min; Fudi Wang
Journal:  Nat Rev Cardiol       Date:  2022-07-04       Impact factor: 49.421

3.  Co-loaded lapatinib/PAB by ferritin nanoparticles eliminated ECM-detached cluster cells via modulating EGFR in triple-negative breast cancer.

Authors:  Xinghan Wu; Huan Sheng; Liping Zhao; Mingxia Jiang; Han Lou; Yue Miao; Ni Cheng; Weifen Zhang; Dejun Ding; Wentong Li
Journal:  Cell Death Dis       Date:  2022-06-20       Impact factor: 9.685

Review 4.  The Role of Ferroptosis in Adverse Left Ventricular Remodeling Following Acute Myocardial Infarction.

Authors:  Kyoko Komai; Nicholas K Kawasaki; Jason K Higa; Takashi Matsui
Journal:  Cells       Date:  2022-04-20       Impact factor: 7.666

Review 5.  Mechanisms of cellular iron sensing, regulation of erythropoiesis and mitochondrial iron utilization.

Authors:  Nunziata Maio; De-Liang Zhang; Manik C Ghosh; Anshika Jain; Anna M SantaMaria; Tracey A Rouault
Journal:  Semin Hematol       Date:  2021-06-27       Impact factor: 3.754

6.  The Role of CD147 in Pathological Cardiac Hypertrophy Is Regulated by Glycosylation.

Authors:  Fang-Yuan Zhong; Yi-Chao Zhao; Chen-Xu Zhao; Zhi-Chun Gu; Xi-Yuan Lu; Wen-Long Jiang; Ling-Chen Gao; Wen-Li Li; Zi-Han Qin; Heng Ge; Jun Pu
Journal:  Oxid Med Cell Longev       Date:  2022-01-20       Impact factor: 6.543

7.  Safety and efficacy of iron supplementation after myocardial infarction in mice with moderate blood loss anaemia.

Authors:  Patricia Wischmann; Ramesh Chennupati; Isabella Solga; Felix Funk; Stefanie Becher; Norbert Gerdes; Stefan Anker; Malte Kelm; Christian Jung
Journal:  ESC Heart Fail       Date:  2021-10-11

Review 8.  Ferroptosis: A Potential Target in Cardiovascular Disease.

Authors:  Yanlong Leng; Xing Luo; Jiaying Yu; Haibo Jia; Bo Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-20

9.  Isolevuglandins Scavenger Ameliorates Myocardial Ischemic Injury by Suppressing Oxidative Stress, Apoptosis, and Inflammation.

Authors:  Junjie Guo; Fengqiang Xu; Hongwei Ji; Yajun Jing; Li Shen; Xinyu Weng; Longgang Hu
Journal:  Front Cell Dev Biol       Date:  2022-03-09

Review 10.  Ironing out mechanisms of iron homeostasis and disorders of iron deficiency.

Authors:  Navid Koleini; Jason S Shapiro; Justin Geier; Hossein Ardehali
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.